Global Biodefense Market Analysis and Forecast 2024-2030

Global Biodefense Market Analysis and Forecast 2024-2030


Summary

Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.

According to APO Research, The global Biodefense market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Biodefense is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Biodefense is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Biodefense is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Biodefense is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Biodefense include Emergent Biosolutions, Hytest, GSK, Sanofi, PharmAthene, Bavarian Nordic, SIGA Technologies, Arbutus Biopharma and DynPort Vaccine, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes

This report presents an overview of global market for Biodefense, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Biodefense, also provides the revenue of main regions and countries. Of the upcoming market potential for Biodefense, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biodefense revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Biodefense market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Biodefense revenue, projected growth trends, production technology, application and end-user industry.

Biodefense segment by Company

Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
Biodefense segment by Type

Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others
Biodefense segment by Application

US Military Market
US Civilian Market
Non - US Market
Biodefense segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biodefense market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biodefense and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biodefense.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Biodefense in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Biodefense company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biodefense revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Biodefense Market by Type
1.2.1 Global Biodefense Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Anthrax
1.2.3 Smallpox
1.2.4 Botulism
1.2.5 Radiation/Nuclear
1.2.6 Others
1.3 Biodefense Market by Application
1.3.1 Global Biodefense Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 US Military Market
1.3.3 US Civilian Market
1.3.4 Non - US Market
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Biodefense Market Dynamics
2.1 Biodefense Industry Trends
2.2 Biodefense Industry Drivers
2.3 Biodefense Industry Opportunities and Challenges
2.4 Biodefense Industry Restraints
3 Global Growth Perspective
3.1 Global Biodefense Market Perspective (2019-2030)
3.2 Global Biodefense Growth Trends by Region
3.2.1 Global Biodefense Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Biodefense Market Size by Region (2019-2024)
3.2.3 Global Biodefense Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Biodefense Revenue by Players
4.1.1 Global Biodefense Revenue by Players (2019-2024)
4.1.2 Global Biodefense Revenue Market Share by Players (2019-2024)
4.1.3 Global Biodefense Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Biodefense Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Biodefense Key Players Headquarters & Area Served
4.4 Global Biodefense Players, Product Type & Application
4.5 Global Biodefense Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Biodefense Market CR5 and HHI
4.6.2 Global Top 5 and 10 Biodefense Players Market Share by Revenue in 2023
4.6.3 2023 Biodefense Tier 1, Tier 2, and Tier 3
5 Biodefense Market Size by Type
5.1 Global Biodefense Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Biodefense Revenue by Type (2019-2030)
5.3 Global Biodefense Revenue Market Share by Type (2019-2030)
6 Biodefense Market Size by Application
6.1 Global Biodefense Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Biodefense Revenue by Application (2019-2030)
6.3 Global Biodefense Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Emergent Biosolutions
7.1.1 Emergent Biosolutions Comapny Information
7.1.2 Emergent Biosolutions Business Overview
7.1.3 Emergent Biosolutions Biodefense Revenue and Gross Margin (2019-2024)
7.1.4 Emergent Biosolutions Biodefense Product Portfolio
7.1.5 Emergent Biosolutions Recent Developments
7.2 Hytest
7.2.1 Hytest Comapny Information
7.2.2 Hytest Business Overview
7.2.3 Hytest Biodefense Revenue and Gross Margin (2019-2024)
7.2.4 Hytest Biodefense Product Portfolio
7.2.5 Hytest Recent Developments
7.3 GSK
7.3.1 GSK Comapny Information
7.3.2 GSK Business Overview
7.3.3 GSK Biodefense Revenue and Gross Margin (2019-2024)
7.3.4 GSK Biodefense Product Portfolio
7.3.5 GSK Recent Developments
7.4 Sanofi
7.4.1 Sanofi Comapny Information
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Biodefense Revenue and Gross Margin (2019-2024)
7.4.4 Sanofi Biodefense Product Portfolio
7.4.5 Sanofi Recent Developments
7.5 PharmAthene
7.5.1 PharmAthene Comapny Information
7.5.2 PharmAthene Business Overview
7.5.3 PharmAthene Biodefense Revenue and Gross Margin (2019-2024)
7.5.4 PharmAthene Biodefense Product Portfolio
7.5.5 PharmAthene Recent Developments
7.6 Bavarian Nordic
7.6.1 Bavarian Nordic Comapny Information
7.6.2 Bavarian Nordic Business Overview
7.6.3 Bavarian Nordic Biodefense Revenue and Gross Margin (2019-2024)
7.6.4 Bavarian Nordic Biodefense Product Portfolio
7.6.5 Bavarian Nordic Recent Developments
7.7 SIGA Technologies
7.7.1 SIGA Technologies Comapny Information
7.7.2 SIGA Technologies Business Overview
7.7.3 SIGA Technologies Biodefense Revenue and Gross Margin (2019-2024)
7.7.4 SIGA Technologies Biodefense Product Portfolio
7.7.5 SIGA Technologies Recent Developments
7.8 Arbutus Biopharma
7.8.1 Arbutus Biopharma Comapny Information
7.8.2 Arbutus Biopharma Business Overview
7.8.3 Arbutus Biopharma Biodefense Revenue and Gross Margin (2019-2024)
7.8.4 Arbutus Biopharma Biodefense Product Portfolio
7.8.5 Arbutus Biopharma Recent Developments
7.9 DynPort Vaccine
7.9.1 DynPort Vaccine Comapny Information
7.9.2 DynPort Vaccine Business Overview
7.9.3 DynPort Vaccine Biodefense Revenue and Gross Margin (2019-2024)
7.9.4 DynPort Vaccine Biodefense Product Portfolio
7.9.5 DynPort Vaccine Recent Developments
7.10 Xoma Corporation
7.10.1 Xoma Corporation Comapny Information
7.10.2 Xoma Corporation Business Overview
7.10.3 Xoma Corporation Biodefense Revenue and Gross Margin (2019-2024)
7.10.4 Xoma Corporation Biodefense Product Portfolio
7.10.5 Xoma Corporation Recent Developments
7.11 Ichor Medical Systems
7.11.1 Ichor Medical Systems Comapny Information
7.11.2 Ichor Medical Systems Business Overview
7.11.3 Ichor Medical Systems Biodefense Revenue and Gross Margin (2019-2024)
7.11.4 Ichor Medical Systems Biodefense Product Portfolio
7.11.5 Ichor Medical Systems Recent Developments
7.12 Aeolus Pharmaceuticals
7.12.1 Aeolus Pharmaceuticals Comapny Information
7.12.2 Aeolus Pharmaceuticals Business Overview
7.12.3 Aeolus Pharmaceuticals Biodefense Revenue and Gross Margin (2019-2024)
7.12.4 Aeolus Pharmaceuticals Biodefense Product Portfolio
7.12.5 Aeolus Pharmaceuticals Recent Developments
7.13 Achaogen
7.13.1 Achaogen Comapny Information
7.13.2 Achaogen Business Overview
7.13.3 Achaogen Biodefense Revenue and Gross Margin (2019-2024)
7.13.4 Achaogen Biodefense Product Portfolio
7.13.5 Achaogen Recent Developments
7.14 Elusys Therapeutics
7.14.1 Elusys Therapeutics Comapny Information
7.14.2 Elusys Therapeutics Business Overview
7.14.3 Elusys Therapeutics Biodefense Revenue and Gross Margin (2019-2024)
7.14.4 Elusys Therapeutics Biodefense Product Portfolio
7.14.5 Elusys Therapeutics Recent Developments
7.15 Dynavax Technologies
7.15.1 Dynavax Technologies Comapny Information
7.15.2 Dynavax Technologies Business Overview
7.15.3 Dynavax Technologies Biodefense Revenue and Gross Margin (2019-2024)
7.15.4 Dynavax Technologies Biodefense Product Portfolio
7.15.5 Dynavax Technologies Recent Developments
7.16 Cleveland BioLabs
7.16.1 Cleveland BioLabs Comapny Information
7.16.2 Cleveland BioLabs Business Overview
7.16.3 Cleveland BioLabs Biodefense Revenue and Gross Margin (2019-2024)
7.16.4 Cleveland BioLabs Biodefense Product Portfolio
7.16.5 Cleveland BioLabs Recent Developments
7.17 Soligenix
7.17.1 Soligenix Comapny Information
7.17.2 Soligenix Business Overview
7.17.3 Soligenix Biodefense Revenue and Gross Margin (2019-2024)
7.17.4 Soligenix Biodefense Product Portfolio
7.17.5 Soligenix Recent Developments
7.18 Alnylam Pharmaceuticals
7.18.1 Alnylam Pharmaceuticals Comapny Information
7.18.2 Alnylam Pharmaceuticals Business Overview
7.18.3 Alnylam Pharmaceuticals Biodefense Revenue and Gross Margin (2019-2024)
7.18.4 Alnylam Pharmaceuticals Biodefense Product Portfolio
7.18.5 Alnylam Pharmaceuticals Recent Developments
8 North America
8.1 North America Biodefense Revenue (2019-2030)
8.2 North America Biodefense Revenue by Type (2019-2030)
8.2.1 North America Biodefense Revenue by Type (2019-2024)
8.2.2 North America Biodefense Revenue by Type (2025-2030)
8.3 North America Biodefense Revenue Share by Type (2019-2030)
8.4 North America Biodefense Revenue by Application (2019-2030)
8.4.1 North America Biodefense Revenue by Application (2019-2024)
8.4.2 North America Biodefense Revenue by Application (2025-2030)
8.5 North America Biodefense Revenue Share by Application (2019-2030)
8.6 North America Biodefense Revenue by Country
8.6.1 North America Biodefense Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Biodefense Revenue by Country (2019-2024)
8.6.3 North America Biodefense Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 Europe
9.1 Europe Biodefense Revenue (2019-2030)
9.2 Europe Biodefense Revenue by Type (2019-2030)
9.2.1 Europe Biodefense Revenue by Type (2019-2024)
9.2.2 Europe Biodefense Revenue by Type (2025-2030)
9.3 Europe Biodefense Revenue Share by Type (2019-2030)
9.4 Europe Biodefense Revenue by Application (2019-2030)
9.4.1 Europe Biodefense Revenue by Application (2019-2024)
9.4.2 Europe Biodefense Revenue by Application (2025-2030)
9.5 Europe Biodefense Revenue Share by Application (2019-2030)
9.6 Europe Biodefense Revenue by Country
9.6.1 Europe Biodefense Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Biodefense Revenue by Country (2019-2024)
9.6.3 Europe Biodefense Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Biodefense Revenue (2019-2030)
10.2 China Biodefense Revenue by Type (2019-2030)
10.2.1 China Biodefense Revenue by Type (2019-2024)
10.2.2 China Biodefense Revenue by Type (2025-2030)
10.3 China Biodefense Revenue Share by Type (2019-2030)
10.4 China Biodefense Revenue by Application (2019-2030)
10.4.1 China Biodefense Revenue by Application (2019-2024)
10.4.2 China Biodefense Revenue by Application (2025-2030)
10.5 China Biodefense Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Biodefense Revenue (2019-2030)
11.2 Asia Biodefense Revenue by Type (2019-2030)
11.2.1 Asia Biodefense Revenue by Type (2019-2024)
11.2.2 Asia Biodefense Revenue by Type (2025-2030)
11.3 Asia Biodefense Revenue Share by Type (2019-2030)
11.4 Asia Biodefense Revenue by Application (2019-2030)
11.4.1 Asia Biodefense Revenue by Application (2019-2024)
11.4.2 Asia Biodefense Revenue by Application (2025-2030)
11.5 Asia Biodefense Revenue Share by Application (2019-2030)
11.6 Asia Biodefense Revenue by Country
11.6.1 Asia Biodefense Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Biodefense Revenue by Country (2019-2024)
11.6.3 Asia Biodefense Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Biodefense Revenue (2019-2030)
12.2 MEALA Biodefense Revenue by Type (2019-2030)
12.2.1 MEALA Biodefense Revenue by Type (2019-2024)
12.2.2 MEALA Biodefense Revenue by Type (2025-2030)
12.3 MEALA Biodefense Revenue Share by Type (2019-2030)
12.4 MEALA Biodefense Revenue by Application (2019-2030)
12.4.1 MEALA Biodefense Revenue by Application (2019-2024)
12.4.2 MEALA Biodefense Revenue by Application (2025-2030)
12.5 MEALA Biodefense Revenue Share by Application (2019-2030)
12.6 MEALA Biodefense Revenue by Country
12.6.1 MEALA Biodefense Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Biodefense Revenue by Country (2019-2024)
12.6.3 MEALA Biodefense Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings